K08670658

Kromasil^® C18 HPLC Column

5 μm particle size, pore size 100 Å, L × I.D. 125 mm × 4 mm

• Sinonimo/i: Kromasil C18
• Codice UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: NB.21

Proprietà

• agenzia: suitable for USP L1
• Nome Commerciale: Kromasil^®
• Produttore/marchio commerciale: Kromasil^® KR100-5-C18-4.0X125
• Disponibilità: available only in USA, Canada and Puerto Rico
• tecniche: HPLC: suitable
• Lungh. × D.I.: 125 mm × 4 mm
• Gruppo funzionale matrice: C18 (octadecyl) phase
• Dimensione particelle: 5 μm
• Dimensione pori: 100 Å
• applicazioni: food and beverages
• Tecnica di separazione: reversed phase

Descrizione

Applicazioni

• QbD-Engineered Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Rutin and Ciprofloxacin HCl in Bilosomal Nanoformulation.: This study leverages the Kromasil^® C18 HPLC Column to develop a robust, quality-by-design (QbD) engineered method for simultaneous estimation of rutin and ciprofloxacin, enhancing analytical accuracy in pharmaceutical formulations (Shamim et al., 2023).


• Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide.: Highlights the use of the Kromasil^® C18 HPLC Column in implementing green analytical chemistry principles for the analysis of zonisamide, contributing to sustainable laboratory practices (Elsheikh et al., 2023).


• Simple high-performance liquid chromatography-ultraviolet method for simultaneous separation and detection of 14 bisphenol pollutants in building materials.: Demonstrates the efficacy of the Kromasil^® C18 HPLC Column in environmental analysis, particularly for the detection of bisphenol pollutants in construction materials, addressing significant environmental health concerns (Han et al., 2023).


• Development and Validation for Quantification of 7-Nitroso Impurity in Sitagliptin by Ultraperformance Liquid Chromatography with Triple Quadrupole Mass Spectrometry.: This paper uses the Kromasil^® C18 HPLC Column for the sensitive detection and quantification of impurities in pharmaceutical products, ensuring drug safety and compliance with regulatory standards (Chittireddy et al., 2022).


• Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.: Utilizes the Kromasil^®C18 HPLC Column to establish a simple and sensitive method for the analysis of Remogliflozin, aiding in the quality control and development of diabetes medication (Itigimatha et al., 2022).

Note legali

Kromasil is a registered trademark of EKA Chemicals AB